Corum Group (COO) Stock Price, News & Analysis

Company Overview

Corum Group Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It operates PharmX, an electronic pharmacy ordering gateway; and PharmXchange, a digital sales and marketing platform integrated with PharmX for pharmacies and their suppliers. The company was formerly known as Cosmos Limited and changed its name to Corum Group Limited in November 2006. Corum Group Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $26.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COO Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Corum Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Corum Group investors own include First Trust Morningstar Dividend Leaders Index Fund (FDL), FT Vest Buffered Allocation Growth ETF (BUFG), DermTech (DMTK), FT Vest S&P 500 Dividend Aristocrats Target Income ETF (KNG), FT Vest Rising Dividend Achievers Target Income ETF (RDVI), Teladoc Health (TDOC) and Consumer Discretionary Select Sector SPDR Fund (XLY).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Medical Equipment
• Current Symbol: ASX:COO
• CIK: N/A
• Web: www.corumgroup.com.au
• Phone: 61 2 9289 4699
• Fax: N/A
• Employees: 14,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -17.46%
• Pretax Margin: N/A
• Return on Equity: -4.63%
• Return on Assets: -1.24%

Debt

• Debt-to-Equity Ratio: 0.14
• Current Ratio: 1.84
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $6.13 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.04 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 597,380,000
• Free Float: N/A
• Market Cap: $26.28 million
• Optionable: Not Optionable
• Beta: 1.52